Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Phoenixbio Co. Ltd. has 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 3 distinct examiners and the same number of distinct art units. GONZALES, JOSEPHINE MARIA is the busiest examiner with 1 pending action.
This distribution suggests that each of the 3 pending matters is being evaluated independently by different examiners in different technical groups. Because there are 3 distinct examiners involved, practitioners should tailor their strategies to each individual. The busiest examiner handles only 1 of the pending actions.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GONZALES, JOSEPHINE MARIA | 1 | 28.8% | +34.6% |
| RAHMAN, MASUDUR | 1 | 72.9% | +31.7% |
| ZHU, JIANJIAN | 1 | 58.1% | +82.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19044583 | HUMAN FATTY-LIVER MODEL CELLS | GONZALES, JOSEPHINE MARIA | — |
| 18696866 | HUMAN HEPATOCYTE CULTURE MEDIUM AND CONDITIONED MEDIUM OF IN VITRO CULTURED HUMAN HEPATOCYTES AND USES THEREOF | RAHMAN, MASUDUR | — |
| 18278605 | HUMAN FATTY-LIVER MODEL CELLS FOR USE IN SCREENING METHOD | ZHU, JIANJIAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19044583 | HUMAN FATTY-LIVER MODEL CELLS | GONZALES, JOSEPHINE MARIA | — |
| 18696866 | HUMAN HEPATOCYTE CULTURE MEDIUM AND CONDITIONED MEDIUM OF IN VITRO CULTURED HUMAN HEPATOCYTES AND USES THEREOF | RAHMAN, MASUDUR | — |
| 18278605 | HUMAN FATTY-LIVER MODEL CELLS FOR USE IN SCREENING METHOD | ZHU, JIANJIAN | — |
| Art Unit | Apps |
|---|---|
| 1638 | 1 |
| 1633 | 1 |
| 1631 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19044583 | HUMAN FATTY-LIVER MODEL CELLS | GONZALES, JOSEPHINE MARIA | 1638 | §101§102§103 | Non-Final OA | — | Pending | Feb 03, 2025 |
| 18696866 | HUMAN HEPATOCYTE CULTURE MEDIUM AND CONDITIONED MEDIUM OF IN VITRO CULTURED HUMAN HEPATOCYTES AND USES THEREOF | RAHMAN, MASUDUR | 1633 | §102§103§112 | Non-Final OA | — | Pending | Mar 28, 2024 |
| 18278605 | HUMAN FATTY-LIVER MODEL CELLS FOR USE IN SCREENING METHOD | ZHU, JIANJIAN | 1631 | §103§112Other | Non-Final OA | — | Pending | Aug 23, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPhoenixbio Co. Ltd. has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Josephine Maria Gonzales has the most, with 1 of Phoenixbio Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
